Connection

Payam Tabarsi to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Payam Tabarsi has written about Drug Therapy, Combination.
Payam Tabarsi
Connection Strength
0.196
Drug Therapy, Combination
  1. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
    View in: PubMed
    Score: 0.080
  2. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
    View in: PubMed
    Score: 0.078
  3. Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial. Int Immunopharmacol. 2021 Oct; 99:108043.
    View in: PubMed
    Score: 0.021
  4. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2018 04; 6(4):265-275.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.